This announcement is a separate document:
Aclaris Therapeutics | CT ORDER: Confidential Treatment Order
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Price
Unlock the Full List
Latest
15:41
Guangwei Composites: Passed the special process certification review in the aviation field
Weihai Guangwei Composites+1.76%
15:41
China International Capital Corporation: Maintains SH PHARMA as "Outperform Industry" rating with a Target Price of 23.3 yuan.
Shanghai Pharmaceuticals Holding-1.64%
15:41
The USA Defense Department has included some Chinese Technology giants in what it calls the "list of Chinese Military Industry companies," to which the Foreign Ministry responded.